See more : HIT Welding Industry Co.,Ltd (301137.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Clarus Therapeutics Holdings, Inc. (CRXWQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clarus Therapeutics Holdings, Inc., a leading company in the industry within the sector.
You may be interested
- Islet Holdings, Inc. (ISHI) Income Statement Analysis – Financial Results
- DIP Corporation (2379.T) Income Statement Analysis – Financial Results
- NTN Corporation (6472.T) Income Statement Analysis – Financial Results
- Laox CO., LTD. (8202.T) Income Statement Analysis – Financial Results
- Shree Krishna Infrastructure L (SKIFL.BO) Income Statement Analysis – Financial Results
Clarus Therapeutics Holdings, Inc. (CRXWQ)
Metric | 2021 | 2020 |
---|---|---|
Revenue | 13.96M | 6.37M |
Cost of Revenue | 2.72M | 8.69M |
Gross Profit | 11.24M | -2.32M |
Gross Profit Ratio | 80.51% | -36.40% |
Research & Development | 3.63M | 2.40M |
General & Administrative | 16.66M | 11.94M |
Selling & Marketing | 30.68M | 30.52M |
SG&A | 47.34M | 42.46M |
Other Expenses | 0.00 | 0.00 |
Operating Expenses | 50.97M | 44.86M |
Cost & Expenses | 53.69M | 53.55M |
Interest Income | 2.00K | 25.00K |
Interest Expense | 15.90M | 15.39M |
Depreciation & Amortization | 27.00K | 43.00K |
EBITDA | -39.71M | -47.13M |
EBITDA Ratio | -284.48% | -740.05% |
Operating Income | -39.73M | -47.18M |
Operating Income Ratio | -284.67% | -740.73% |
Total Other Income/Expenses | -885.00K | 51.52M |
Income Before Tax | -40.62M | 4.35M |
Income Before Tax Ratio | -291.02% | 68.22% |
Income Tax Expense | 15.90M | 15.39M |
Net Income | -56.51M | -11.05M |
Net Income Ratio | -404.90% | -173.48% |
EPS | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 |
Weighted Avg Shares Out | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 |
No news found for: CRXWQ
Source: https://incomestatements.info
Category: Stock Reports